Hall of Fame player Dwyane Wade said doctors performed a December 2023 surgery on his kidney to remove a tumor later ...

Robert Santos, who emphasized inclusivity and outreach to overlooked communities, has resigned as director of the U.S. Census ...

An inflation gauge closely watched by the Federal Reserve rose slightly last month, the latest sign that some consumer prices remain stubbornly elevated, even as inflation is ...

Russia on Friday claimed it had captured another village in its relentless offensive in eastern Ukraine’s Donetsk region and as it closes in on the critical Ukrainian ...

The 25% tax that President Donald Trump plans to slap on imports from Canada and Mexico as soon as Saturday could drive up the price of everything from gasoline and pickup ...

Exxon Mobil posted strong fourth quarter profits as the oil and gas company increased production in the Permian basin at home, and in Guyana. The Texas company earned $7.61 billion, or $1.72 per ...

After spending a freezing night out in the open, hundreds of striking students on Friday resumed their 2-day anti-graft ...

Air crash investigations can take months, and federal investigators told reporters they would not speculate on the cause.

A Norwegian-owned and Russian-crewed ship that authorities suspect may have been involved in damage to an underwater fiber optic cable connecting Latvia and the Swedish island ...

President Trump’s torrent of executive actions has spurred a flood of legal challenges seeking to thwart the president’s ...

The offseason addition of Saquon Barkley helped elevate a sluggish offense for the Philadelphia Eagles and lead the team to a ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.